Haematological cancers include various diseases (Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, leukaemia and multiple myeloma. The term leukaemia comprises acute myeloid leukaemia, chronic myelogenous leukaemia, acute lymphoblastic leukaemia and chronic lymphoblastic leukaemia); they can affect children, young adults and the elderly, and their incidence increases with age.1 As liquid tumours moving in the blood or lymph, acute or chronic diseases, with side effects induced by different treatments, are unique. Just as these diseases are distinct entities showing many differences from solid tumours, so too is the manner in which they are managed. In 1999, leukaemias and lymphomas accounted for approximately 8% of all cancers in adults. Carcinogenesis or oncogenesis or tumorigenesis is the genuine arrangement of a disease, whereby typical cells are changed into malignant growth cells. The procedure is portrayed by a movement of changes at the cell, hereditary, and epigenetic level that at last reconstruct a cell to experience uncontrolled cell division, along these lines shaping a dangerous mass. Diary of colorectal malignant growth, diary of Adenocarcinoma, Journal of Neoplasam, diary of neurooncolgy, Chinese diary of oncology, Clinical and Translational oncology, Current opinon in Oncology, European diary of Oncology, European diary Oncology Pharmacy